{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:14:42Z","timestamp":1788372882745,"version":"build-2803163510"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020896","name":"Zayed Bin Sultan Center for Health Sciences, United Arab Emirates University","doi-asserted-by":"publisher","award":["#12R282"],"award-info":[{"award-number":["#12R282"]}],"id":[{"id":"10.13039\/501100020896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Viral respiratory infections still exist as a major global health concern. Influenza A viruses and human metapneumoviruses are among the main pathogens responsible for infections that can progress to severe acute respiratory forms. Despite the availability of certain therapeutic options, the need for effective treatment remains an issue. The exploration of innovative approaches based on medicinal plants, capable of simultaneously targeting several viruses, represents a promising strategic option for limiting the viral activity of these pathogens. In this work, an integrated computational workflow combining molecular docking, ADMET prediction, molecular dynamics (MD) simulations, and MM-PBSA binding free-energy analysis was applied to evaluate previously reported antiviral phytoconstituents for their broad-spectrum antiviral potential by simultaneously targeting influenza A virus neuraminidase (NA) (PDB ID: 2HT7) and the human metapneumovirus (HMPV) fusion protein (F) (PDB ID: 7SEJ). Molecular docking analyses identified 37 phytoconstituents with favorable multi-target binding affinities toward both NA and F proteins, exhibiting more favorable predicted binding energies than the reference compounds oseltamivir and ribavirin. In addition, ADMET prediction, including bioavailability assessment and analysis of pharmacokinetic and toxicological properties, identified several compounds with favorable profiles, notably compounds E10, M294, M329, C11, C5, and M274. MD simulations followed by MM-PBSA binding free-energy calculations further validated the stability and binding behavior of the highest-ranked protein\u2013ligand complexes identified through the sequential screening workflow. Overall, compounds M294 and C11 emerged as the most promising broad-spectrum antiviral lead candidates against both influenza A NA and HMPV F protein. Nevertheless, these findings are based on computational predictions and require confirmation through in vitro antiviral assays followed by in vivo studies.<\/jats:p>","DOI":"10.1371\/journal.pone.0348517","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:29:52Z","timestamp":1788370192000},"page":"e0348517","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repositioning antiviral phytoconstituents as broad-spectrum inhibitors of influenza A neuraminidase and human metapneumovirus fusion protein"],"prefix":"10.1371","volume":"21","author":[{"given":"Nouh","family":"Mounadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Nour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u2019hammed","family":"El Kouali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-4471","authenticated-orcid":true,"given":"Abdelouahid","family":"Samadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2344-5101","authenticated-orcid":true,"given":"Samir","family":"Chtita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"10127","key":"pone.0348517.ref001","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"AD Iuliano","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"pone.0348517.ref002","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000004221","article-title":"Epidemiology and Clinical Characteristics of Human Metapneumovirus Infections in Hospitalized Children in Two Consecutive Postpandemic Years","volume":"43","author":"R Steinberg","year":"2024","journal-title":"Pediatr Infect Dis J"},{"issue":"21","key":"pone.0348517.ref003","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1021\/acs.jcim.5c00992","article-title":"Exploring Drug Repurposing for Influenza A (H3N2) Virus: A Computational Approach to Identifying Commercialized Drugs Targeting Hemagglutinin, Neuraminidase, and Nucleoprotein","volume":"65","author":"N Mounadi","year":"2025","journal-title":"J Chem Inf Model"},{"issue":"3","key":"pone.0348517.ref004","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1039\/D0RA07283D","article-title":"Recent progress in chemical approaches for the development of novel neuraminidase inhibitors","volume":"11","author":"A Mahal","year":"2021","journal-title":"RSC Adv"},{"issue":"9","key":"pone.0348517.ref005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0332170","article-title":"Exploring Dolichos lablab compounds as potential inhibitors for fusion (F) protein of human metapneumovirus (HMPV): A systematic computational approach","volume":"20","author":"MM Hossain","year":"2025","journal-title":"PLoS One"},{"key":"pone.0348517.ref006","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s42250-024-00914-5","article-title":"Computational studies of cannabis derivatives as potential inhibitors of SARS-CoV-2 Mpro","volume":"5","author":"N Mounadi","year":"2024","journal-title":"Chemistry Africa"},{"issue":"5","key":"pone.0348517.ref007","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/0115734064318657240822064240","article-title":"Exploring Cannabis sativa L for Anti-Alzheimer Potential: An Extensive Computational Study including Molecular Docking, Molecular Dynamics, and ADMET Assessments","volume":"21","author":"H Nour","year":"2025","journal-title":"Med Chem"},{"key":"pone.0348517.ref008","doi-asserted-by":"crossref","DOI":"10.1016\/j.sciaf.2023.e01745","article-title":"Exploration of Cannabis constituents as potential candidates against diabetes mellitus disease using molecular docking, dynamics simulations and ADMET investigations","volume":"21","author":"O Abchir","year":"2023","journal-title":"Scientific African"},{"issue":"4","key":"pone.0348517.ref009","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15545","article-title":"Repositioning Cannabinoids and Terpenes as Novel EGFR-TKIs Candidates for Targeted Therapy Against Cancer: A virtual screening model using CADD and biophysical simulations","volume":"9","author":"O Daoui","year":"2023","journal-title":"Heliyon"},{"issue":"2","key":"pone.0348517.ref010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/ph19020315","article-title":"Integrated Computational Investigation of Cannabis sativa Phytoconstituents as Putative Multi-Target Inhibitors in Skin Cancer: A Molecular Docking, Dynamics, and ADMET Profiling Study","volume":"19","author":"LE Bouamri","year":"2026","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"pone.0348517.ref011","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/jccs.202200195","article-title":"Discovery of promising cholinesterase inhibitors for Alzheimer\u2019s disease treatment through DFT, docking, and molecular dynamics studies of eugenol derivatives","volume":"69","author":"H Nour","year":"2022","journal-title":"J Chinese Chemical Soc"},{"issue":"2","key":"pone.0348517.ref012","first-page":"289","article-title":"Discovery of eugenol-derived drug candidates for the treatment of COVID-19 by applying molecular docking, molecular dynamics, and pharmacokinetic analysis","volume":"12","author":"N Mounadi","year":"2024","journal-title":"Physical Chemistry Research"},{"key":"pone.0348517.ref013","doi-asserted-by":"crossref","DOI":"10.1016\/j.sciaf.2025.e02969","article-title":"In silico analysis of Moroccan medicinal plant compounds as potential inhibitors of influenza A (H3N2)","volume":"30","author":"N Mounadi","year":"2025","journal-title":"Scientific African"},{"key":"pone.0348517.ref014","unstructured":"Protein Data Bank. Crystal structure of neuraminidase (PDB ID: 2HT7). 2026. https:\/\/www.rcsb.org\/structure\/2HT7 Accessed 2026 January 3."},{"key":"pone.0348517.ref015","unstructured":"Protein Data Bank. Fusion protein of human metapneumovirus (PDB ID: 7SEJ). 2026. https:\/\/www.rcsb.org\/structure\/7SEJ Accessed 2026 January 3."},{"issue":"2","key":"pone.0348517.ref016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"O Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"pone.0348517.ref017","article-title":"Discovery Studio [Computer software]","author":"BIOVIA","year":"2021","journal-title":"Dassault Syst\u00e8mes"},{"key":"pone.0348517.ref018","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"A Daina","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0348517.ref019","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"P Banerjee","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"pone.0348517.ref020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"CA Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"pone.0348517.ref021","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"DF Veber","year":"2002","journal-title":"J Med Chem"},{"key":"pone.0348517.ref022","unstructured":"Schr\u00f6dinger LLC. Desmond. 2020. https:\/\/www.schrodinger.com\/platform\/products\/desmond"},{"issue":"3","key":"pone.0348517.ref023","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1021\/acs.jctc.8b01026","article-title":"OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules","volume":"15","author":"K Roos","year":"2019","journal-title":"J Chem Theory Comput"},{"issue":"46","key":"pone.0348517.ref024","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"P Mark","year":"2001","journal-title":"Journal of Physical Chemistry A"},{"issue":"12","key":"pone.0348517.ref025","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: A new molecular dynamics method","volume":"52","author":"M Parrinello","year":"1981","journal-title":"Journal of Applied Physics"},{"issue":"7","key":"pone.0348517.ref026","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Open Source Drug Discovery Consortium","year":"2014","journal-title":"J Chem Inf Model"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0348517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:30:00Z","timestamp":1788370200000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0348517"}},"subtitle":[],"editor":[{"given":"Lalit","family":"Samant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0348517","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}